A Phase 3 interventional study of Risedronate in Acute Spinal Cord Injury., sponsored by Toronto Rehabilitation Institute. Completed at 2 sites in Canada. Open to participants aged 16 Years to 60 Years. Per ClinicalTrials.gov, last updated 2007-11-21.
Sponsored by Toronto Rehabilitation Institute · Phase 3, Interventional, and Prevention
The purpose of this study is to find out if Risedronate works to prevent osteoporosis after spinal cord injury.
1,640 studies on the registry are indexed under Osteoporosis; 212 are open to participants now.
This study's enrollment of 38 is below the median of 95 across 1,133 interventional studies indexed under Osteoporosis.
Browse Osteoporosis studies →Toronto Rehabilitation Institute is the lead sponsor of 39 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Change in bone mineral density of the distal femur and proximal tibia between baseline, 12-months and 24-months.
Change in bone mineral density of the total body, spine and femoral neck between baseline, 12-months and 24-months.
Change in biochemical markers of bone turnover between baseline, 12-months and 24-months.
Frequency and severity of adverse events.
Quality of life.
This study is completed, as verified in Nov 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Toronto Rehabilitation Institute